Nutricircle Limited Reports Robust Financial Performance for Q2 and H1 FY2026

2 min read     Updated on 13 Nov 2025, 11:07 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Nutricircle Limited announced unaudited financial results for Q2 and H1 FY2026, showing substantial growth. Revenue from operations reached ₹515.16 lakh in Q2 and ₹734.33 lakh in H1. Profit After Tax stood at ₹6.40 lakh for Q2 and ₹9.54 lakh for H1. The company's balance sheet strengthened with total assets of ₹1,237.24 lakh and total equity of ₹589.35 lakh as of September 30, 2025. In December 2024, the company raised ₹9.73 crore through equity allotment. Management expressed confidence in the company's performance and future growth prospects.

powered bylight_fuzz_icon
24601050

*this image is generated using AI for illustrative purposes only.

Nutricircle Limited , formerly known as Shreeyash Industries Limited, has announced its unaudited financial results for the second quarter and first half of the fiscal year 2025-26, showcasing significant growth in revenue and profitability.

Financial Highlights

The company reported a substantial increase in its revenue from operations for the quarter ended September 30, 2025. Here's a breakdown of the key financial metrics:

Particulars Q2 FY2026 H1 FY2026
Revenue from Operations ₹515.16 ₹734.33
Total Income ₹515.16 ₹734.33
Profit Before Tax ₹6.40 ₹9.54
Profit After Tax ₹6.40 ₹9.54

All figures in lakh rupees

The company's performance shows a remarkable improvement compared to the previous year, with revenue from operations for the half-year reaching ₹734.33 lakh, up from nil in the corresponding period of the previous fiscal year.

Operational Performance

Nutricircle Limited's cost of materials consumed for H1 FY2026 stood at ₹669.74 lakh, indicating a significant increase in operational activity. The company managed to keep its employee benefits expenses stable at ₹7.93 lakh for the half-year period.

Balance Sheet Strengthening

As of September 30, 2025, Nutricircle Limited reported:

  • Total Assets: ₹1,237.24 lakh
  • Total Equity: ₹589.35 lakh
  • Current Assets: ₹1,234.34 lakh

The company's balance sheet shows a notable improvement in its financial position, with a significant increase in current assets and total assets compared to the previous fiscal year-end.

Capital Raising and Equity Expansion

In December 2024, Nutricircle Limited completed a significant equity allotment:

  • Allotted 97,28,220 equity shares at ₹10 per share
  • Total amount raised: ₹9.73 crore
  • Additionally issued 11,00,000 share warrants convertible into equity shares

This capital infusion is expected to provide the company with funds to support its growth initiatives and operational expansion.

Management Commentary

Hitesh Mohanlal Patel, Managing Director of Nutricircle Limited, stated, "Our financial results for Q2 and H1 FY2026 reflect the company's strong operational performance and strategic initiatives. The significant growth in revenue and profitability demonstrates the effectiveness of our business model and the growing demand for our products. The recent capital raise will further strengthen our financial position and enable us to capitalize on emerging opportunities in the market."

Auditor's Review

NSVR & Associates LLP, the company's statutory auditors, have conducted a limited review of the financial results. They have stated that nothing has come to their attention that causes them to believe that the financial statements do not present a true and fair view in accordance with applicable accounting standards and other recognized accounting practices and policies.

Outlook

With a strengthened balance sheet and improved operational performance, Nutricircle Limited appears well-positioned for continued growth. The company's focus on expanding its operations and the recent capital infusion are expected to support its future expansion plans and market positioning.

Historical Stock Returns for Nutricircle

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%-3.95%-6.78%+101.23%+73.82%+779.90%

Nutricircle Limited Inks Exclusive Distribution Deal with Barentz for Life Science Ingredients

1 min read     Updated on 26 Aug 2025, 06:41 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Nutricircle Limited has entered into an exclusive distribution agreement with Barentz Distribution India Private Limited for marketing and distributing its life science ingredients. The five-year agreement, signed on August 25, 2025, appoints Barentz as the sole distributor in the specified territory. Nutricircle must fulfill orders within 115% of estimated annual volume, with payments in Indian Rupees due within 60 days. The deal is not a related party transaction and complies with SEBI regulations.

powered bylight_fuzz_icon
17759503

*this image is generated using AI for illustrative purposes only.

Nutricircle Limited , a company specializing in life science ingredients, has entered into a significant exclusive distribution agreement with Barentz Distribution India Private Limited. The deal, signed on August 25, 2025, marks a strategic move for Nutricircle to expand its market reach and distribution capabilities.

Key Details of the Agreement

The agreement appoints Barentz as the exclusive distributor for marketing, distribution, and resale of Nutricircle's products in the specified territory. This exclusivity clause means that Nutricircle will refrain from appointing other distributors or directly supplying its products to any other entity in the designated area.

Terms and Conditions

  • Duration: The agreement has an initial term of five years from the effective date and will automatically renew for additional one-year periods unless terminated with six months' written notice.

  • Order Fulfillment: Nutricircle, as the principal, must accept all purchase orders from Barentz within 115.00% of the estimated annual volume requirements. The company will also make best efforts to fulfill orders exceeding this threshold.

  • Payment Terms: All payments will be made in Indian Rupees within 60 days of the invoice date.

Strategic Implications

This partnership leverages Barentz's position as a global distributor of life science ingredients, potentially opening new markets for Nutricircle's products. The agreement's structure suggests a commitment to long-term collaboration between the two companies.

Transparency and Compliance

Nutricircle Limited has confirmed that this transaction does not fall within the category of related party transactions, and neither party is related to promoter groups. This disclosure aligns with the company's commitment to transparency and compliance with Securities and Exchange Board of India (SEBI) regulations.

Market Impact

While the financial details of the agreement have not been disclosed, the exclusive nature of the partnership could potentially lead to increased sales volumes for Nutricircle Limited. Investors and market analysts will likely keep a close eye on how this agreement impacts the company's future financial performance and market position in the life science ingredients sector.

As the agreement takes effect, stakeholders will be watching for any noticeable changes in Nutricircle's business operations and financial results in the coming quarters.

Historical Stock Returns for Nutricircle

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%-3.95%-6.78%+101.23%+73.82%+779.90%

More News on

1 Year Returns:+73.82%